Joseph P. Lyssikatos

Insider Reports History

Location
Boulder, CO
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph P. Lyssikatos:

Company Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 740,188 $18,785,971 $25.38 12 Feb 2026 Indirect
Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 18,750 $475,875 $25.38 12 Feb 2026 Direct
Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (right to buy) 112,500 12 Feb 2026 Direct

Insider Reports Filed by Joseph P. Lyssikatos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELVN Enliven Therapeutics, Inc. 12 Feb 2026 2 $0 4 CHIEF SCIENTIFIC OFFICER 17 Feb 2026, 19:52
ELVN Enliven Therapeutics, Inc. 06 Feb 2026 1 -$145,219 4 CHIEF SCIENTIFIC OFFICER 10 Feb 2026, 18:12
ELVN Enliven Therapeutics, Inc. 20 Jan 2026 2 -$535,099 4 CHIEF SCIENTIFIC OFFICER 22 Jan 2026, 17:34
ELVN Enliven Therapeutics, Inc. 08 Jan 2026 4 -$3,476,014 4 CHIEF SCIENTIFIC OFFICER 12 Jan 2026, 17:12
ELVN Enliven Therapeutics, Inc. 19 Dec 2025 1 -$84,206 4 CHIEF SCIENTIFIC OFFICER 23 Dec 2025, 18:45
ELVN Enliven Therapeutics, Inc. 19 Nov 2025 2 -$279,155 4 CHIEF SCIENTIFIC OFFICER 21 Nov 2025, 17:28
ELVN Enliven Therapeutics, Inc. 20 Oct 2025 1 -$276,025 4 CHIEF SCIENTIFIC OFFICER 22 Oct 2025, 19:20
ELVN Enliven Therapeutics, Inc. 26 Sep 2025 1 -$81,005 4 CHIEF SCIENTIFIC OFFICER 30 Sep 2025, 17:53
ELVN Enliven Therapeutics, Inc. 23 Sep 2025 1 -$30,045 4 CHIEF SCIENTIFIC OFFICER 25 Sep 2025, 19:44
ELVN Enliven Therapeutics, Inc. 19 Sep 2025 2 -$135,697 4 CHIEF SCIENTIFIC OFFICER 23 Sep 2025, 17:14
ELVN Enliven Therapeutics, Inc. 19 Aug 2025 2 -$248,216 4 CHIEF SCIENTIFIC OFFICER 21 Aug 2025, 18:46
ELVN Enliven Therapeutics, Inc. 21 Jul 2025 2 -$278,646 4 CHIEF SCIENTIFIC OFFICER 23 Jul 2025, 18:52
ELVN Enliven Therapeutics, Inc. 20 Jun 2025 1 -$267,458 4 CHIEF SCIENTIFIC OFFICER 24 Jun 2025, 17:36
ELVN Enliven Therapeutics, Inc. 03 Jun 2025 1 -$150,220 4 CHIEF SCIENTIFIC OFFICER 05 Jun 2025, 16:55
ELVN Enliven Therapeutics, Inc. 19 May 2025 1 -$81,534 4 CHIEF SCIENTIFIC OFFICER 21 May 2025, 18:31
ELVN Enliven Therapeutics, Inc. 01 May 2025 2 -$150,391 4 CHIEF SCIENTIFIC OFFICER 05 May 2025, 18:43
ELVN Enliven Therapeutics, Inc. 21 Apr 2025 2 -$80,366 4 CHIEF SCIENTIFIC OFFICER 23 Apr 2025, 17:09
ELVN Enliven Therapeutics, Inc. 19 Mar 2025 1 -$257,575 4 CHIEF SCIENTIFIC OFFICER 21 Mar 2025, 17:49
ELVN Enliven Therapeutics, Inc. 06 Feb 2025 1 $0 4 CHIEF SCIENTIFIC OFFICER 10 Feb 2025, 17:29
ELVN Enliven Therapeutics, Inc. 18 Oct 2024 1 -$25,413 4 CHIEF SCIENTIFIC OFFICER 22 Oct 2024, 16:22
ELVN Enliven Therapeutics, Inc. 08 Oct 2024 4 -$1,437,585 4 CHIEF SCIENTIFIC OFFICER 10 Oct 2024, 20:39
ELVN Enliven Therapeutics, Inc. 04 Oct 2024 2 -$281,664 4 CHIEF SCIENTIFIC OFFICER 08 Oct 2024, 18:58
ELVN Enliven Therapeutics, Inc. 01 Oct 2024 1 -$14,512 4 CHIEF SCIENTIFIC OFFICER 03 Oct 2024, 18:47
ELVN Enliven Therapeutics, Inc. 29 Aug 2024 2 -$269,841 4 CHIEF SCIENTIFIC OFFICER 03 Sep 2024, 17:43
ELVN Enliven Therapeutics, Inc. 31 Jul 2024 1 -$85,399 4 CHIEF SCIENTIFIC OFFICER 02 Aug 2024, 19:26
ELVN Enliven Therapeutics, Inc. 29 Jul 2024 2 -$320,378 4 CHIEF SCIENTIFIC OFFICER 31 Jul 2024, 19:33
ELVN Enliven Therapeutics, Inc. 01 Jul 2024 1 -$274,736 4 CHIEF SCIENTIFIC OFFICER 03 Jul 2024, 16:31
ELVN Enliven Therapeutics, Inc. 29 May 2024 4 -$247,360 4 CHIEF SCIENTIFIC OFFICER, Director 31 May 2024, 16:05
ELVN Enliven Therapeutics, Inc. 29 Apr 2024 4 -$201,548 4 CHIEF SCIENTIFIC OFFICER, Director 01 May 2024, 19:04
ELVN Enliven Therapeutics, Inc. 11 Apr 2024 3 -$717,732 4 CHIEF SCIENTIFIC OFFICER, Director 15 Apr 2024, 19:06
ELVN Enliven Therapeutics, Inc. 01 Apr 2024 5 -$209,706 4 CHIEF SCIENTIFIC OFFICER, Director 03 Apr 2024, 21:30
ELVN Enliven Therapeutics, Inc. 29 Feb 2024 4 -$183,566 4 CHIEF SCIENTIFIC OFFICER, Director 04 Mar 2024, 17:55
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4 CHIEF SCIENTIFIC OFFICER, Director 15 Feb 2024, 21:00
ELVN Enliven Therapeutics, Inc. 29 Jan 2024 3 -$176,816 4 CHIEF SCIENTIFIC OFFICER, Director 31 Jan 2024, 21:22
ELVN Enliven Therapeutics, Inc. 29 Dec 2023 4 -$157,941 4 Chief Scientific Officer, Director 03 Jan 2024, 19:01
ELVN Enliven Therapeutics, Inc. 21 Dec 2023 6 -$78,436 4 Chief Scientific Officer, Director 26 Dec 2023, 19:32
ELVN Enliven Therapeutics, Inc. 19 Dec 2023 6 -$105,691 4 Chief Scientific Officer, Director 21 Dec 2023, 16:29
ELVN Enliven Therapeutics, Inc. 03 Nov 2023 3 -$102,179 4 Chief Scientific Officer, Director 06 Nov 2023, 16:43
ELVN Enliven Therapeutics, Inc. 29 Sep 2023 3 -$150,058 4 Chief Scientific Officer, Director 03 Oct 2023, 19:40
ELVN Enliven Therapeutics, Inc. 04 Apr 2023 1 $0 4 Chief Scientific Officer, Director 06 Apr 2023, 20:33
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 3 $0 4 Chief Scientific Officer, Director 27 Feb 2023, 20:34
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 0 $0 3 Chief Scientific Officer, Director 27 Feb 2023, 20:26